Cybex International defends intellectual property rights related to patented Plate Loaded Leg Press

NewsGuard 100/100 Score

Cybex International, Inc. (NASDAQ: CYBI), a leading manufacturer of premium exercise equipment, announced today that it has decisively responded to infringements of its intellectual property rights related to its patented Plate Loaded Leg Press and the company's pending patent applications for the Bravo Functional Trainer.

“This has resulted in dozens of patents for our industry-leading strength and cardio training equipment. Some of our competitors may be looking for short cuts and find it easier to copy than to innovate. We will always strive to protect the intellectual property we've worked so hard to create.”

CYBEX conducted investigations during the recent International Health, Racquet & Sportsclub Association (IHRSA) trade show in San Diego, CA, which uncovered four separate violations of its intellectual property. CYBEX immediately responded by demanding that the offending parties cease and desist from manufacturing, selling or importing into the US products which incorporate CYBEX intellectual property, and each party has agreed to comply with this demand.

"CYBEX devotes a tremendous amount of time, energy and resources to research and development," says Ray Giannelli, CYBEX Senior Vice President, Research and Development. "This has resulted in dozens of patents for our industry-leading strength and cardio training equipment. Some of our competitors may be looking for short cuts and find it easier to copy than to innovate. We will always strive to protect the intellectual property we've worked so hard to create."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis